Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis

Full metadata record
DC Field Value Language
dc.contributor.authorKoh, Hyun Min-
dc.contributor.authorLee, Hyun Ju-
dc.contributor.authorKim, Dong Chul-
dc.date.accessioned2021-10-05T04:43:11Z-
dc.date.available2021-10-05T04:43:11Z-
dc.date.issued2021-07-
dc.identifier.issn2218-676X-
dc.identifier.issn2219-6803-
dc.identifier.urihttps://scholarworks.bwise.kr/sch/handle/2021.sw.sch/19880-
dc.description.abstractBackground: Recent studies have shown that CD90 has an important role in cancer development. Moreover, CD90 is reportedly associated with cancer progression, metastasis, and poor prognosis. Thus, we performed this meta-analysis to investigate the prognostic and clinicopathological value of CD90 expression in patients with cancer. Methods: Eligible studies were collected by searching PubMed, Embase, and the Cochrane library. The pooled results were analyzed to reveal the association between CD90 expression and survival as well as the clinicopathological characteristics of cancer patients. Results: CD90 overexpression was associated with poor survival in cancer patients [for overall survival, hazard ratio (HR): 2.56, 95% confidence interval (CI): 1.42-4.62, P=0.002; for disease-free survival, HR: 1.88, 95% CI: 1.08-3.27, P=0.025] and was also significantly correlated with a larger tumor size [odds ratio (OR): 1.97, 95% CI: 1.01-3.85, P=0.048), higher tumor grade (OR: 2.72, 95% CI: 1.33-5.54, P=0.006), lymph node metastasis (OR: 3.66, 95% CI: 1.14-11.78, P=0.029), and higher tumor-node-metastasis stage (OR: 4.79, 95% CI: 2.28-10.04, P<0.001). Conclusions: CD90 overexpression could predict poor prognosis and may hence be a potential prognostic biomarker for cancer patients.-
dc.format.extent8-
dc.language영어-
dc.language.isoENG-
dc.publisherAME Publishing Company-
dc.titlePrognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis-
dc.typeArticle-
dc.publisher.location중국-
dc.identifier.doi10.21037/tcr-21-266-
dc.identifier.scopusid2-s2.0-85111672320-
dc.identifier.wosid000691480000019-
dc.identifier.bibliographicCitationTranslational Cancer Research, v.10, no.7, pp 3356 - 3363-
dc.citation.titleTranslational Cancer Research-
dc.citation.volume10-
dc.citation.number7-
dc.citation.startPage3356-
dc.citation.endPage3363-
dc.type.docTypeReview-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaOncology-
dc.relation.journalWebOfScienceCategoryOncology-
dc.subject.keywordPlusSURVIVAL-
dc.subject.keywordAuthorCancer-
dc.subject.keywordAuthorCD90-
dc.subject.keywordAuthormeta-analysis-
dc.subject.keywordAuthorprognosis-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Pathology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Hyun Joo photo

Lee, Hyun Joo
College of Medicine (Department of Pathology)
Read more

Altmetrics

Total Views & Downloads

BROWSE